(Q73707445)
Statements
Preclinical toxicity and efficacy study of a 14-day schedule of oral 5-iodo-2-pyrimidinone-2'-deoxyribose as a prodrug for 5-iodo-2'-deoxyuridine radiosensitization in U251 human glioblastoma xenografts (English)
Kinsella TJ
Vielhuber KA
Kunugi KA
Schupp J
Davis TW